These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 1668133)

  • 1. Changes in the enzyme activity of the myocardium and participation of the alpha-adrenergic and M-cholinergic systems in experimental isoprenaline myocardial hypertrophy.
    Kolarova R; Petkov O; Popova N
    Acta Physiol Pharmacol Bulg; 1991; 17(2-3):111-7. PubMed ID: 1668133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Some functional changes in experimentally induced cardiac overload.
    Petkov O
    Acta Physiol Pharmacol Bulg; 1983; 9(3):42-50. PubMed ID: 6230880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dynamic biochemical, metrometric and histomorphological studies in isoproterenol-induced myocardial hypertrophy and its regression in rats].
    Prodanov K; Kolarova R; Tsakova L; Balutsov M
    Eksp Med Morfol; 1991; 30(1):26-30. PubMed ID: 1832104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect of preliminary administration of dimethylsulfoxide on the development of experimental myocardial necrosis in rats treated with isoprenaline].
    Ljubuncić P; Mujić F; Stojiljković MP; Vinterhalter-Jadrić M
    Srp Arh Celok Lek; 1991; 119(9-10):238-42. PubMed ID: 1806990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of myocardial hypertrophy in prehypertensive spontaneously hypertensive rats: interaction between adrenergic and nitrosative pathways.
    Cabassi A; Dancelli S; Pattoneri P; Tirabassi G; Quartieri F; Moschini L; Cavazzini S; Maestri R; Lagrasta C; Graiani G; Corradi D; Parenti E; Tedeschi S; Cremaschi E; Coghi P; Vinci S; Fiaccadori E; Borghetti A
    J Hypertens; 2007 Aug; 25(8):1719-30. PubMed ID: 17620971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Action of the antihypertensive effect of captopril on manifestations of hypertrophy and several parameters of myocardial metabolism].
    Kolarova R; Petkov O
    Biull Eksp Biol Med; 1990 Aug; 110(8):131-3. PubMed ID: 2291953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. L-arginine inhibits isoproterenol-induced cardiac hypertrophy through nitric oxide and polyamine pathways.
    Lin Y; Wang LN; Xi YH; Li HZ; Xiao FG; Zhao YJ; Tian Y; Yang BF; Xu CQ
    Basic Clin Pharmacol Toxicol; 2008 Aug; 103(2):124-30. PubMed ID: 18816294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of quinapril, losartan and hydralazine on cardiac hypertrophy and beta-adrenergic neuroeffector mechanisms in transgenic (mREN2)27 rats.
    Zolk O; Flesch M; Schnabel P; Teisman AC; Pinto YM; van Gilst WH; Paul M; Böhm M
    Br J Pharmacol; 1998 Feb; 123(3):405-12. PubMed ID: 9504380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac hypertrophy induced by alpha- and beta-adrenergic receptor stimulation.
    Zimmer HG; Kolbeck-Ruhmkorff C; Zierhut W
    Cardioscience; 1995 Mar; 6(1):47-57. PubMed ID: 7605896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of myocardial cell necrosis with experimental cardiac hypertrophy.
    Revis NW; Cameron AJ
    J Pathol; 1979 Aug; 128(4):193-202. PubMed ID: 160447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of adrenergic receptors during regression of cardiac hypertrophy.
    Matsui H; Makino N; Yano K; Nakanishi H; Hata T; Yanaga T
    J Hypertens; 1994 Dec; 12(12):1353-7. PubMed ID: 7706693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increases in alpha-but not beta-adrenoceptors in hypertrophied non-infarcted cardiac muscles from rats with chronic myocardial infarction.
    Itaya T; Hashimoto H; Satoh R; Uematsu T; Nakashima M
    Jpn J Pharmacol; 1990 Aug; 53(4):513-8. PubMed ID: 2170725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Enzymatic activity of the glycolytic and pentosemonophosphate pathways of carbohydrate conversion in the heart in hypertrophy].
    Denisov VM
    Vopr Med Khim; 1980; 26(1):51-5. PubMed ID: 6445126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypertrophy-associated gene induction after beta-adrenergic stimulation in adult cardiomyocytes.
    Taimor G; Schlüter K; Piper HM
    J Mol Cell Cardiol; 2001 Mar; 33(3):503-11. PubMed ID: 11181018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical alterations in cardiac hypertrophy.
    Khairallah PA; Hanna MK; Tarazi RC; Upsher ME; Yoshida K
    J Hypertens Suppl; 1984 Dec; 2(3):S379-82. PubMed ID: 6242562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Myocardial phosphorylase activity in rats with spontaneous and metacorticoid hypertension treated with isoprenaline and untreated].
    Bogoslovova T; Staneva D
    Eksp Med Morfol; 1980; 19(1):21-5. PubMed ID: 7389642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in sarcolemmal adenosine triphosphatase activity and in ouabain sensitivity of rat myocardium in isoproterenol-induced cardiac hypertrophy.
    Szabó J; Nosztray K; Szegi J
    Pol J Pharmacol Pharm; 1989; 41(6):553-9. PubMed ID: 2562064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of peroxisome proliferator-activated receptor alpha activation in acute myocardial damage induced by isoproterenol in rats.
    Yuan J; Wu J; Hang ZG; Zhong XK; Zhou LW; Yu B
    Chin Med J (Engl); 2008 Aug; 121(16):1569-73. PubMed ID: 18982870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urotensin II accelerates cardiac fibrosis and hypertrophy of rats induced by isoproterenol.
    Zhang YG; Li YG; Liu BG; Wei RH; Wang DM; Tan XR; Bu DF; Pang YZ; Tang CS
    Acta Pharmacol Sin; 2007 Jan; 28(1):36-43. PubMed ID: 17184580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of alpha and beta adrenergic receptors blockade on the adrenolytic effect of muscular work.
    Janczewska H; Bogdański W; Trzebski A
    Acta Physiol Pol; 1980; 31(5):469-74. PubMed ID: 6263042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.